PMV Pharma: Winston Kung
Winston Kung has accepted the position of chief operating officer (COO) and chief financial officer (CFO) at PMV Pharmaceuticals in New Jersey state, US.
Prior to joining PMV Pharma, Kung held positions as vice president of business development and global alliances at Celgene, and chief business officer at Celgene Cellular Therapeutics.
Kung told us he has joined PMV Pharma – which is developing p53 pathway modulators for the treatment of cancer – to help advance the company’s world-class research and emerging pipeline.
“Like many people, I have family and friends who have been impacted by cancer. I’m excited to be part of the exceptional team bringing important and novel medicines to patients.
“Given the importance of p53 – the most commonly-mutated gene in cancer, linked to approximately 50% of all tumours – our vision is to transform the treatment paradigm in oncology,” he told us.
Holiday plans?
“I am planning to take my kids to see the new Star Wars movie,” he told us.
“We’ll also be hosting extended family from out of town for the holidays and plan to take them to visit New York City,” he added.